Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression.
about
DPP4 in DiabetesDipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protectionHypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism.Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trialReduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs.Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology.Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes.Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.The protein and neutral lipid composition of lipid droplets isolated from the fission yeast, Schizosaccharomyces pombe.Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus.The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health
P2860
Q26797335-C15A126A-9937-46F1-BC1E-3911BAE848D0Q27011819-EFC5FA8B-EB8F-4C91-8FB0-A642D3ECAC8FQ33789096-D047A5DA-3BB0-4354-AE70-1EE52424F2C1Q35860311-06B28114-1454-46B0-AA23-D8EBEDC3E3E9Q35891473-F0BDBCC8-20B2-4339-96B7-B19C2ED27748Q36307279-D9E9C8F7-4C1C-4FBF-96CF-0FB117E8AB70Q38107546-1ED6BEDA-715D-4518-B8E6-C27B13861838Q38110890-BE03A602-422B-4218-92C5-592278310AECQ38922177-03C77189-9F9D-4A79-A38C-690687EF33FDQ39044029-2F652AA9-AEC7-4087-946E-0E8DA2B515ADQ39717289-4FB14355-6E6C-4631-AFC7-05A142A7C9B0Q42377919-736513EA-CFEA-4604-BE7B-3E135D6ADC96Q51030102-32D67BFB-439E-4ADF-BA0A-73DCF947FE51Q51726149-5F86B20D-7E69-4F87-89A9-722D3D50A55CQ58719667-0757BE69-F3A9-47B3-BC71-1FCCCCE496CF
P2860
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@en
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@nl
type
label
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@en
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@nl
prefLabel
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@en
Dipeptidyl-peptidase-IV by cle ...... ulation and PPAR-γ expression.
@nl
P50
P1433
P1476
Dipeptidyl-peptidase-IV by cle ...... mulation and PPAR-γ expression
@en
P2093
Eric Grouzmann
Vera Cortez
P356
10.1016/J.PEPTIDES.2012.06.014
P577
2012-07-20T00:00:00Z